Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

The appropriate omalizumab patient.

Karpel J, Bukstein DA, LoNigro R.

Manag Care. 2007 May;16(5):44-50, 56.

2.

Omalizumab as add-on therapy to inhaled steroids for asthma.

Hadj Tahar A.

Issues Emerg Health Technol. 2004 Jun;(58):1-4.

PMID:
15455487
3.

Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.

D'Amato G, Liccardi G, Noschese P, Salzillo A, D'Amato M, Cazzola M.

Curr Drug Targets Inflamm Allergy. 2004 Sep;3(3):227-9. Review.

PMID:
15379589
4.

Omalizumab: a novel therapy for allergic asthma.

Davis LA.

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1236-42. Epub 2004 Jun 8. Review.

PMID:
15187202
5.

Anti-IgE antibodies for the treatment of asthma.

Buhl R.

Curr Opin Pulm Med. 2005 Jan;11(1):27-34. Review.

PMID:
15591885
6.
8.

Reduction of the total IgE level by omalizumab in children and adolescents.

Steiss JO, Strohner P, Zimmer KP, Lindemann H.

J Asthma. 2008 Apr;45(3):233-6. doi: 10.1080/02770900701883782.

PMID:
18415832
9.

Omalizumab: a review of its use in the treatment of allergic asthma.

Plosker GL, Keam SJ.

BioDrugs. 2008;22(3):189-204. Review.

PMID:
18481901
10.

[New principles and possibilities in the treatment of asthma].

Janner JH, Ulrik CS.

Ugeskr Laeger. 2007 Mar 12;169(11):995-7. Review. Danish.

PMID:
17371631
11.

Anti-immunoglobulin E therapy with omalizumab for asthma.

Hendeles L, Sorkness CA.

Ann Pharmacother. 2007 Sep;41(9):1397-410. Epub 2007 Aug 14. Review.

PMID:
17698897
12.

Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.

Niven R, Chung KF, Panahloo Z, Blogg M, Ayre G.

Respir Med. 2008 Oct;102(10):1371-8. doi: 10.1016/j.rmed.2008.06.002. Epub 2008 Jul 26.

13.

The use of omalizumab in asthma.

Price D.

Prim Care Respir J. 2008 Jun;17(2):62-72. doi: 10.3132/pcrj.2008.00031. Review.

14.

Omalizumab: efficacy in allergic disease.

Spector S.

Panminerva Med. 2004 Jun;46(2):141-8. Review.

15.

[Omalizumab (Xolair). Product description].

Laursen LC.

Ugeskr Laeger. 2007 Mar 12;169(11):993-5. Danish.

PMID:
17371630
16.
17.

Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.

Nowak D.

Respir Med. 2006 Nov;100(11):1907-17. Epub 2006 Sep 1. Review.

18.

Omalizumab for severe asthma?

[No authors listed]

Drug Ther Bull. 2006 Nov;44(11):86-8. Review.

PMID:
17089921
19.

An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.

Sullivan SD, Turk F.

Allergy. 2008 Jun;63(6):670-84. doi: 10.1111/j.1398-9995.2008.01723.x. Review.

20.

Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection.

Cruz AA, Lima F, Sarinho E, Ayre G, Martin C, Fox H, Cooper PJ.

Clin Exp Allergy. 2007 Feb;37(2):197-207.

Supplemental Content

Support Center